Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

MSCL.TO Relative to the S&P 500

MSCL.TO Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Satellos Bioscience Inc. (TSE:MSCL.TO) seasonal charts above shows that a Buy Date of February 1 and a Sell Date of June 2 has resulted in a geometric average return of 5.37% above the benchmark rate of the S&P 500 Total Return Index over the past 16 years. This seasonal timeframe has shown positive results compared to the benchmark in 11 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 16 years by an average of 27.18% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company’s?program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

To download MSCL.TO seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: MSCL.TO